When was RxFunction founded?

RxFunction was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Where is RxFunction located?

RxFunction is headquartered in Minneapolis, United States. It is registered at Eden Prairie, Minnesota.

Who is the current CEO of RxFunction?

Mary Ernst Anderson of RxFunction.

How many employees does RxFunction have?

As of Jun 30, 2026, the latest employee count at RxFunction is 88.

Is RxFunction a funded company?

RxFunction is a funded company, having raised a total of $39.9M across 12 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 14, 2011.

When was the latest funding round of RxFunction?

RxFunction's latest funding was a $***** Series B round on Oct 27, 2022, with participation from 0 investor.

Where does RxFunction rank among its competitors?

RxFunction ranks 10th amongst 106 active competitors, of which 40 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Wearable Robotics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of RxFunction?

RxFunction's top competitors include HyperIce, AxoGen and Fundamental Surgery. Among them, Wearable Robotics secured the most recent funding round in April, 2026.

RxFunction - 2026 Company Profile, Team, Funding & Competitors

RxFunction is a series B company based in Minneapolis (United States), founded in 2010. It operates as a Provider of wearable prosthesis for people with sensory peripheral neuropathy. RxFunction has raised $39.9M in funding. The company has 106 active competitors, including 40 funded and 9 that have exited. Its top competitors include companies like HyperIce, AxoGen and Fundamental Surgery.

Company Details

RxFunction provides wearable prostheses for people with sensory peripheral neuropathy. It develops advanced balance technology solutions, aiming to aid patients with loss of balance. The product consists of a leg unit and a footpad (insoles). The product's insoles measure the patient's foot pressure and provide real-time tactile sensory cues to help control balance and stability. The leg unit wraps around the lower leg of the user and contains electronics for reading the insole signals, a microprocessor as well as four vibrating motors that provide tactile sensory cues to the user.

Website: rxfunction.com
Social
Email ID: *****@rxfunction.com
Registered Address: Eden Prairie, Minnesota

Key Metrics

Founded Year

2010

Location

Minneapolis, United States

Stage

Series B

Total Funding

$39.9M in 12 rounds

Latest Funding Round

Series B, Oct 27, 2022, $*****

Investors

HHS & 1 more

Ranked

10^th among 106 active competitors

Employee Count

88 as on Jun 30, 2026

Similar Companies

AxoGen & 107 more

View RxFunction's full profile

RxFunction is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
RXFUNCTION, INC. CIN: 273029348 , United States, Active	May 16, 2010	-	65 (As on Dec 31, 2024)	-

RxFunction has raised a total funding of $39.9M over 12 rounds. Its first funding round was on Sep 14, 2011. RxFunction has 2 institutional investors.

Here is the list of recent funding rounds of RxFunction:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 27, 2022	6440041	Series B	6073410	3927650	4942541	7357145
Jan 14, 2021	5800096	Series A	8349058	5392531	5555370	6453723
Dec 09, 2020	8789307	Series A	8028282	2436186	6070044	3035109

Access funding benchmarks and valuations. Sign up today!

View details of RxFunction's funding rounds and investors

Here are the details of RxFunction's key team members:

Mary Ernst Anderson: CEO of RxFunction.
Contact Info: 1 email address

RxFunction's Board of Directors

RxFunction's board has 15 active members. Robert Rinek, Lars Oddsson, Kevin Roche, Mary Anderson, Richard Offerdahl, Kevin H. Roche, Joseph Daniel Leach, Thomas Morizio, Thomas E. Morizio, Richard J. Nigon, Mary E. Anderson, Richard Nigon, Robert P. Rinek, Joseph D. Leach and Joseph Schauer are independent board members.

Here is the list of RxFunction's board of directors:

Name	Type	Representing	Status	Duration
Robert Rinek	Independent board member	-	Current	8y 6m
ruz{ulh	Independent board member	-	Current	1y 3m
pggjmur	Independent board member	-	Current	7y 8m
exnbiln	Independent board member	-	Current	3y 2m
aunvvlk	Independent board member	-	Current	9y 8m
zlqefgc	Independent board member	-	Current	1y 6m
oabocmf	Independent board member	-	Current	1y 5m
inncpby	Independent board member	-	Current	9y 6m
dvxk{qx	Independent board member	-	Current	1y 3m
iubywmk	Independent board member	-	Current	8y 1m
tvmj{wg	Independent board member	-	Current	2y 5m
{ujzctz	Independent board member	-	Current	9y 1m
rqegwef	Independent board member	-	Current	6y 8m
{ysggkj	Independent board member	-	Current	6y 6m
vupnmfj	Independent board member	-	Current	2y 8m

View details of RxFunction's Founder profiles and Board Members

RxFunction's employee count trend

RxFunction has 88 employees as of Jun 26. Here is RxFunction's employee count trend over the years:

Uncover RxFunction's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RxFunction include HyperIce, AxoGen and Fundamental Surgery. Here is the list of Top 10 competitors of RxFunction, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	HyperIce 2011, Irvine (United States), Series C	Internet first brand offering smart devices for physical fitness	$52.5M	MainStreet Advisors, SC.Holdings & 38 others	68/100
2nd	AxoGen 2002, Alachua (United States), Public	Developer of therapies for the repair of peripheral nerve injuries	$62.4M	Oberland Capital, Cardinal Partners & 10 others	65/100
3rd	Fundamental Surgery 2012, Boston (United States), Series B	Provider of AI-based platform for surgical simulation using VR and haptics	$39.6M	EQT, Founders Factory & 13 others	63/100
4th	Neocis 2012, Miami (United States), Series D	Provider of robotic guidance system for dental surgeries	$179M	Norwest, DFJ Growth & 12 others	63/100
5th	Tulavi Nerve Therapeutics 2020, Mountain View (United States), Series A	Developer of the therapeutic device to treat neurally mediated diseases	$11.5M	Ascension Ventures, AMED Ventures & 1 others	57/100
6th	Wearable Robotics 2014, Pisa (Italy), Series A	Exoskeletons and robotic rehabilitation devices	$8.51M	CDP Venture Capital, Progress Tech Transfer ... & 8 others	52/100
7th	Startoon Labs 2017, Secunderabad (India), Seed	Developer of medical device for physiotherapy assessment, monitoring, and reporting	$465K	IKP Knowledge Park, Guptaji invests & 14 others	52/100
8th	KT Tape 2009, American Fork (United States), Acquired	Manufacturer of kinesiology tape, health products, and related application accessories	-	Palladin Consumer Retail Partners	52/100
9th	MedRhythms 2013, Boston (United States), Series B	Provider of wearable devices to combat neurological injuries and recover walking functions	$63.2M	Morningside, Advantage Capital & 10 others	51/100
10th	RxFunction 2010, Minneapolis (United States), Series B	Provider of wearable prosthesis for people with sensory peripheral neuropathy	$39.9M	HHS & 1 others	47/100